Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,072 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Modified Drug-Susceptibility Testing and Screening Culture Agar for Colistin-Susceptible Enterobacteriaceae Isolates Harboring a Mobilized Colistin Resistance Gene mcr-9.
Kananizadeh P, Tada T, Oshiro S, Hishinuma T, Tohya M, Uehara Y, Kumagai Y, Nagaoka I, Nishi K, Hashimoto M, Watanabe S, Kirikae T. Kananizadeh P, et al. Among authors: uehara y. J Clin Microbiol. 2022 Dec 21;60(12):e0139922. doi: 10.1128/jcm.01399-22. Epub 2022 Nov 29. J Clin Microbiol. 2022. PMID: 36445156 Free PMC article.
The impact of carbapenem shortage and stewardship countermeasures on antimicrobial practice at a tertiary care center.
Kouyama Y, Uehara Y, Takamatsu A, Suzuki R, Nishida R, Inuzuka K, Muramatsu E, Ohyama K, Doi Y, Yamada S, Honda H. Kouyama Y, et al. Among authors: uehara y. Antimicrob Steward Healthc Epidemiol. 2023 Oct 19;3(1):e173. doi: 10.1017/ash.2023.460. eCollection 2023. Antimicrob Steward Healthc Epidemiol. 2023. PMID: 38028913 Free PMC article.
Letter to the editor: Importance of considering high-risk behaviours in COVID-19 vaccine effectiveness estimates with observational studies.
Arashiro T, Arima Y, Kuramochi J, Muraoka H, Sato A, Chubachi K, Oba K, Yanai A, Arioka H, Uehara Y, Ihara G, Kato Y, Yanagisawa N, Nagura Y, Yanai H, Ueda A, Numata A, Kato H, Oka H, Nishida Y, Ooki T, Nidaira Y, Stucky A, Suzuki T, Smith C, Hibberd M, Ariyoshi K, Suzuki M. Arashiro T, et al. Among authors: uehara y. Euro Surveill. 2023 Jan;28(4):2300034. doi: 10.2807/1560-7917.ES.2023.28.4.2300034. Euro Surveill. 2023. PMID: 36700869 Free PMC article. No abstract available.
Effectiveness of BA.1- and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan.
Arashiro T, Arima Y, Kuramochi J, Muraoka H, Sato A, Chubachi K, Yanai A, Arioka H, Uehara Y, Ihara G, Kato Y, Yanagisawa N, Ueda A, Kato H, Oka H, Nishida Y, Nidaira Y, Asami T, Jinta T, Nakamura A, Oba K, Taniyama D, Yamamoto K, Tanaka K, Ueshima K, Fuwa T, Stucky A, Suzuki T, Smith C, Hibberd M, Ariyoshi K, Suzuki M. Arashiro T, et al. Among authors: uehara y. Open Forum Infect Dis. 2023 May 3;10(6):ofad240. doi: 10.1093/ofid/ofad240. eCollection 2023 Jun. Open Forum Infect Dis. 2023. PMID: 37351451 Free PMC article.
1,072 results